Teladoc | Diabetes and Weight Management Part 2-Weight Management Treatment Options Infographic

Weight Management Treatment Options Infographic

Pdf Summary

This document provides guidelines for weight management treatment options for individuals with type 2 diabetes, based on recommendations from the American Diabetes Association's Standards of Care in Diabetes—2023. <br /><br />The guidelines suggest using behavioral strategies to support diabetes self-management and promote optimal diabetes health outcomes. Specifically, setting SMART (specific, measurable, actionable, timely, realistic) goals is recommended. <br /><br />The document discusses various pharmacological agents that can be used for weight management. It provides information on common side effects and possible safety concerns for medications such as phentermine, phentermine/topiramate ER, naltrexone/bupropion ER, liraglutide, and semaglutide. Black box warnings are noted for certain medications, such as the risk of suicidal behavior in young individuals with depression and the risk of thyroid C-cell tumors in rodents (although the human relevance is not determined). <br /><br />Short-term and long-term treatment options are also mentioned, including sympathomimetic amine anorectics, sympathomimetic amine anorectic/antiepileptic combinations, opioid antagonist/antidepressant combinations, and glucagon-like peptide 1 receptor agonists. <br /><br />The document emphasizes the importance of a person-centered approach and "SMART" (specific, measurable, actionable, timely, realistic) lifestyle modifications for weight management. It also mentions the use of orlistat, a lipase inhibitor, as an anti-obesity medication. <br /><br />For more detailed information on approved obesity pharmacotherapy options, readers are directed to refer to Section 8 of The American Diabetes Association's Standards of Care in Diabetes—2023.

Keywords

Weight management treatment options

Type 2 diabetes

American Diabetes Association

Standards of Care in Diabetes—2023

Behavioral strategies

SMART goals

Pharmacological agents

Side effects

Safety concerns

Obesity pharmacotherapy